Retraction
KYA1797K down-regulates PD-L1 in colon cancer stem cells to block immune evasion by suppressing the β-catenin/STT3 signaling pathway
Paper Information
Record ID:
43243
Journal:
Publication Date:
December 05, 2019
Retraction Date:
March 13, 2023
(2.7 years years ago)
Subjects:
Institutions:
Country:
🇨🇳 ChinaArticle Type:
Publisher:
Elsevier
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Retraction Details
Retraction Reasons:
Nature of Retraction:
Retraction
Retraction Notice:
10.1016/j.intimp.2023.109928Additional Notes:
see also: https://pubpeer.com/publications/DCF33B20702DC3AE0C9D750A90174B
Citations (42)
42
Total Citations8
Post-Retraction(19.0%)
34
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
0
Within 30 days
6
Within 1 year
0
After 2+ years
722
Days since retraction (latest)
Capsanthin inhibits migration and reduces N-linked glycosylation of PD-L1 via the EZH2-PD-L1 axis in triple-negative breast cancer brain metastasis
Yi‐Chung Chien, Jiayan Wu, Liang‐Chih Liu et al. (4 authors)
Cell Death Discovery
Open Access
Published: Mar 2025
2 citations
2 citations
722 days after retraction
Stromal Reprogramming Optimizes KRAS-Specific Chemotherapy Inducing Antitumor Immunity in Pancreatic Cancer
Qinglian Hu, Jiayu Feng, Lulu Qi et al. (4 authors)
ACS Applied Materials & Interfaces
Published: Oct 2024
1 citation
1 citation
598 days after retraction
Delta-tocotrienol disrupts PD-L1 glycosylation and reverses PD-L1-mediated immune suppression
Zhenou Sun, Xuan Ma, Chong Zhao et al. (6 authors)
Biomedicine & Pharmacotherapy
Open Access
Published: Dec 2023
8 citations
8 citations
291 days after retraction
Navigating Tumour Microenvironment and Wnt Signalling Crosstalk: Implications for Advanced Cancer Therapeutics
Shraddha Shravani Peri, Krithicaa Narayanaa Y., T. Hubert et al. (10 authors)
Cancers
Open Access
Published: Dec 2023
5 citations
5 citations
276 days after retraction
Oncofetal reprogramming in tumor development and progression: novel insights into cancer therapy
Jiangjun Cao, Zhe Zhang, Li Zhou et al. (10 authors)
MedComm
Open Access
Published: Dec 2023
9 citations
9 citations
263 days after retraction
Immune checkpoint inhibitors for multiple myeloma immunotherapy
Zhaoyun Liu, Xintong Xu, Hui Liu et al. (6 authors)
Experimental Hematology and Oncology
Open Access
Published: Nov 2023
23 citations
23 citations
260 days after retraction
Regulation of post-translational modification of PD-L1 and advances in tumor immunotherapy
Chong Feng, Lening Zhang, Xin Chang et al. (5 authors)
Frontiers in Immunology
Open Access
Published: Jul 2023
22 citations
22 citations
133 days after retraction
Sfrp2 regulates the WNT/β-catenin pathway to slow the development of aldosterone-producing adenoma
Erli Yang, Chandong Ding, Xiaoxia Zhu et al. (8 authors)
Cardiovascular Diagnosis and Therapy
Open Access
Published: Jun 2023
3 citations
3 citations
80 days after retraction
Role of regulation of PD-1 and PD-L1 expression in sepsis
Teng Zhang, Yujing Li, Tao Ma
Frontiers in Immunology
Open Access
Published: Mar 2023
28 citations
28 citations
4 days before retraction
Structural N-glycoproteomics characterization of cell-surface N-glycosylation of MCF-7/ADR cancer stem cells
Hailun Yang, Feifei Xu, Yun Chen et al. (4 authors)
Journal of Chromatography B
Published: Feb 2023
5 citations
5 citations
18 days before retraction
A Potential Off-Target Effect of the Wnt/β-Catenin Inhibitor KYA1797K: PD-L1 Binding and Checkpoint Inhibition
Xavier Thuru, Romain Magnez, Gérard Vergoten et al. (4 authors)
Biomedicine Hub
Open Access
Published: Jan 2023
4 citations
4 citations
53 days before retraction
Blocking the Wnt/β‑catenin signaling pathway to treat colorectal cancer: Strategies to improve current therapies (Review)
Yuxiang Chen, Mo Chen, Kai Deng
International Journal of Oncology
Open Access
Published: Dec 2022
46 citations
46 citations
76 days before retraction
B7 family protein glycosylation: Promising novel targets in tumor treatment
Linlin Xiao, Xiaoyan Guan, Mingli Xiang et al. (9 authors)
Frontiers in Immunology
Open Access
Published: Dec 2022
16 citations
16 citations
97 days before retraction
Butein suppresses PD-L1 expression via downregulating STAT1 in non-small cell lung cancer
Lin Zhao, Wenxin Zhang, Fengming Luan et al. (9 authors)
Biomedicine & Pharmacotherapy
Open Access
Published: Nov 2022
15 citations
15 citations
105 days before retraction
The Glycosylation of Immune Checkpoints and Their Applications in Oncology
Linlin Zheng, Qi Yang, Feifei Li et al. (11 authors)
Pharmaceuticals
Open Access
Published: Nov 2022
16 citations
16 citations
110 days before retraction
Elevation of spermine remodels immunosuppressive microenvironment through driving the modification of PD-L1 in hepatocellular carcinoma
Hong‐Xiang Shi, Chao Liang, Chao‐Yan Yao et al. (12 authors)
Cell Communication and Signaling
Open Access
Published: Nov 2022
14 citations
14 citations
125 days before retraction
Sohlh2 Regulates the Stemness and Differentiation of Colon Cancer Stem Cells by Downregulating LncRNA-H19 Transcription
Ruihong Zhang, Xiaoli Zhang, Wenfang Zhang et al. (12 authors)
Molecular Cancer Research
Open Access
Published: Oct 2022
5 citations
5 citations
138 days before retraction
Tumor immune checkpoints and their associated inhibitors
Zerui Gao, Xing Yi Ling, Chengyu Shi et al. (5 authors)
Journal of Zhejiang University SCIENCE B
Open Access
Published: Oct 2022
18 citations
18 citations
163 days before retraction
The miR-3648/FRAT1-FRAT2/c-Myc negative feedback loop modulates the metastasis and invasion of gastric cancer cells
Weimei Tang, Miaomiao Pei, Jiaying Li et al. (23 authors)
Oncogene
Open Access
Published: Sep 2022
18 citations
18 citations
170 days before retraction
WNT signaling in the tumor microenvironment promotes immunosuppression in murine pancreatic cancer
Wenting Du, Rosa E. Menjivar, Katelyn L. Donahue et al. (12 authors)
The Journal of Experimental Medicine
Open Access
Published: Sep 2022
45 citations
45 citations
186 days before retraction
Current insight into the regulation of PD-L1 in cancer
Zhuandi Liu, Xibao Yu, Ling Xu et al. (5 authors)
Experimental Hematology and Oncology
Open Access
Published: Jul 2022
67 citations
67 citations
226 days before retraction
Research progress of <scp>PD‐L1</scp> non‐glycosylation in cancer immunotherapy
Pu Cao, Xiaoyan Yang, Daquan Liu et al. (7 authors)
Scandinavian Journal of Immunology
Published: Jul 2022
4 citations
4 citations
244 days before retraction
Blockage of PD‐L1 by FERMT3‐mediated Wnt/β‐catenin signalling regulates chemoresistance and immune evasion of colorectal cancer cells
Yanhua Tang, Nan Nan, Chuan-Zhi Gui et al. (6 authors)
Clinical and Experimental Pharmacology and Physiology
Published: Jun 2022
9 citations
9 citations
278 days before retraction
Analysis of Tumor Glycosylation Characteristics and Implications for Immune Checkpoint Inhibitor’s Efficacy for Breast Cancer
Wenchang Lv, Honghao Yu, Han Mei et al. (8 authors)
Frontiers in Immunology
Open Access
Published: Apr 2022
14 citations
14 citations
343 days before retraction
Mechanisms regulating PD-L1 expression in cancers and associated opportunities for novel small-molecule therapeutics
Hirohito Yamaguchi, Jung-Mao Hsu, Wenhao Yang et al. (4 authors)
Nature Reviews Clinical Oncology
Published: Feb 2022
350 citations
350 citations
399 days before retraction
Deglycosylation of SLAMF7 in breast cancers enhances phagocytosis.
Shih-Han Wang, Wen‐Cheng Chou, Hsiang‐Chi Huang et al. (18 authors)
PubMed
Published: Jan 2022
10 citations
10 citations
436 days before retraction
Citrus Flavones Luteolin and Apigenin Target Fundamental Mechanisms in Colon Cancer
Rama Rao Malla, Ganji Ganji
Onco Therapeutics
Published: Jan 2022
436 days before retraction
A Novel Prognostic Biomarker Panel for Early-Stage Colon Carcinoma
Pablo Azcue, David Guerrero Setas, Ignacio Encı́o et al. (7 authors)
Cancers
Open Access
Published: Nov 2021
7 citations
7 citations
474 days before retraction
A scoping review on the potentiality of PD-L1-inhibiting microRNAs in treating colorectal cancer: Toward single-cell sequencing-guided biocompatible-based delivery
Mahdi Abdoli Shadbad, Zahra Asadzadeh, Afshin Derakhshani et al. (12 authors)
Biomedicine & Pharmacotherapy
Open Access
Published: Sep 2021
26 citations
26 citations
537 days before retraction
PDIA6 promotes pancreatic cancer progression and immune escape through CSN5-mediated deubiquitination of β-catenin and PD-L1
Yihui Ma, Peiyi Xia, Zhengyang Wang et al. (6 authors)
Neoplasia
Open Access
Published: Jul 2021
28 citations
28 citations
595 days before retraction
Deubiquitinating Enzymes Orchestrate the Cancer Stem Cell-Immunosuppressive Niche Dialogue: New Perspectives and Therapeutic Potential
Junnan Guo, Bairong Xia, Shen-Hui Deng et al. (7 authors)
Frontiers in Cell and Developmental Biology
Open Access
Published: Jun 2021
8 citations
8 citations
642 days before retraction
The Role of Glycosyltransferases in Colorectal Cancer
Cecilia Fernández-Ponce, Noelia Geribaldi‐Doldán, Ismael Sánchez-Gomar et al. (10 authors)
International Journal of Molecular Sciences
Open Access
Published: May 2021
42 citations
42 citations
652 days before retraction
Co-delivery of IOX1 and doxorubicin for antibody-independent cancer chemo-immunotherapy
Jing Liu, Zhihao Zhao, Nasha Qiu et al. (10 authors)
Nature Communications
Open Access
Published: Apr 2021
129 citations
129 citations
689 days before retraction
PD-L1 as a Prognostic Factor in Early-Stage Colon Carcinoma within the Immunohistochemical Molecular Subtype Classification
Pablo Azcue, Ignacio Encı́o, David Guerrero Setas et al. (8 authors)
Cancers
Open Access
Published: Apr 2021
17 citations
17 citations
695 days before retraction
RPN2 Predicts Poor Prognosis and Promotes Bladder Cancer Growth and Metastasis via the PI3K-Akt Pathway
Chenglin Han, Shuxiao Chen, Haiyang Ma et al. (9 authors)
OncoTargets and Therapy
Open Access
Published: Mar 2021
16 citations
16 citations
742 days before retraction
MicroRNA-15a Carried by Mesenchymal Stem Cell-Derived Extracellular Vesicles Inhibits the Immune Evasion of Colorectal Cancer Cells by Regulating the KDM4B/HOXC4/PD-L1 Axis
Lei Liu, Ting Yu, Yanping Jin et al. (6 authors)
Frontiers in Cell and Developmental Biology
Open Access
Published: Mar 2021
32 citations
32 citations
742 days before retraction
Suppression of Wnt/β-catenin and RAS/ERK pathways provides a therapeutic strategy for gemcitabine-resistant pancreatic cancer
Won-Ji Ryu, Gyoonhee Han, Soung-Hoon Lee et al. (4 authors)
Biochemical and Biophysical Research Communications
Open Access
Published: Mar 2021
26 citations
26 citations
742 days before retraction
Research progress on O-GlcNAcylation in the occurrence, development, and treatment of colorectal cancer
Yao Liu, Fangxing Peng
World Journal of Gastrointestinal Surgery
Open Access
Published: Feb 2021
3 citations
3 citations
767 days before retraction
Spatial and Temporal Changes in PD-L1 Expression in Cancer: The Role of Genetic Drivers, Tumor Microenvironment and Resistance to Therapy
Elena Shklovskaya, Helen Rizos
International Journal of Molecular Sciences
Open Access
Published: Sep 2020
52 citations
52 citations
897 days before retraction
Research progress of PD-1/PD-L1 immunotherapy in gastrointestinal tumors
Jiangang Sun, Yi‐Chao Zheng, MAA Mamun et al. (6 authors)
Biomedicine & Pharmacotherapy
Open Access
Published: Jul 2020
36 citations
36 citations
978 days before retraction
Inhibition of MicroRNA-302c on Stemness of Colon Cancer Stem Cells via the CARF/Wnt/β-Catenin Axis
Yun Zhang, Hua Meng, Kun Guo
Digestive Diseases and Sciences
Published: Jul 2020
13 citations
13 citations
984 days before retraction
Aptamer/Peptide‐Functionalized Genome‐Editing System for Effective Immune Restoration through Reversal of PD‐L1‐Mediated Cancer Immunosuppression
Xiaoyan He, Xiaohe Ren, Yan Peng et al. (8 authors)
Advanced Materials
Published: Mar 2020
118 citations
118 citations
1099 days before retraction
Quick Stats
Total Citations:
42
Years Since Retraction:
2.7 years
Open Access:
Yes
Last Checked:
Jul 24, 2025